Normal proliferation of T cells in vitro requires production of and response to the lymphokine interleukin 2 (IL-2). Optimal IL-2 production by T cells is dependent on the monokine interleukin 1 (IL-1). A 10-year-old male with recurrent infections and failure to thrive was evaluated for possible defects in the production and response to IL-1 and IL-2. The patient had normal levels of serum immunoglobulins and a normal distribution of circulating T-cell subsets. However, the in vitro proliferative response of his peripheral blood mononuclear cells (PBMC) to phytohemagglutinin was depressed (40% of normal) and the response of his PBMC to antigens was absent. Delayed hypersensitivity skin tests and in vitro response to tetanus toxoid remained absent despite repeated immunizations. Monocyte function in this patient was normal as judged by the following criteria: normal expression of Ia antigens (77% +), normal IL-1 production, and normal capacity to present tetanus toxoid to a maternal T-cell line specific for tetanus toxoid antigen. The abnormal phytohemagglutinin response of the patient's PBMC was corrected by the addition of exogenous IL-2. IL-2 production by the patient's phytohemagglutin-stimulated PBMC was severely deficient but was corrected by the addition of phorbol 12-myristate 13-acetate, suggesting a defective response to IL-1. T-cell blasts derived from a normal subject but not T-cell blasts derived from the patient absorbed out IL-1 activity from a preparation of purified human IL-1. These results indicate that the patient's T-cell deficiency was due to a defective T-cell response to IL-1 and suggest that IL-1 plays an important role in the in vivo immune response.
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The proliferative response of human T cells to antigen requires the recognition of antigen processed by Ia' accessory cells and the monokine interleukin 1 (IL-1). These two requirements can be separated by irradiation of the antigenpulsed accessory cells with UV light, which inhibits the production of IL-1 (1) (2) (3) (4) . The failure of T cells to proliferate to UV-treated antigen-pulsed monocytes (Mo) is reversed by the addition of purified IL-1 (3). The requirement for IL-1 for T-cell proliferation to mitogens such as phytohemagglutinin (PHA) and Con A is less clear. Rabbit antibody to human IL-1 does not inhibit the proliferation of peripheral blood mononuclear cells (PBMC) to mitogens cells but readily inhibits the proliferation of PBMC to antigen such as tetanus toxoid (TT) (3, 5) . IL-1 induces T cells that have interacted with lectins to secrete interleukin 2 (IL-1) (6, 7) . In turn, IL-2 causes the proliferation of activated T cells, which express IL-2 receptors. We now describe a patient with an inability to generate IL-2 due to a defect in his T-cell response to IL-1.
CASE REPORT
A 10-year-old Lebanese male had a history of recurrent pneumonias and otitis media beginning at the age of 2 
MATERIALS AND METHODS
Cells and Cell Cultures. The isolations of PBMC and of highly enriched populations of Mo and of T cells were done as described (8) . Proliferation of PBMC to antigens and mitogens was performed as described in ref. 9 .
Production and Assay of IL-2. IL-2 was generated by culturing nonadherent irradiated (1000 rads; 1 rad = 0.01 gray) PBMC (106 cells per ml) with PHA for 48 hr as described (10) . IL-2 activity in the supernatants was assayed on Con Ainduced IL-2-dependent T-cell lines as described in ref. 10 .
PHA-free IL-2 was a gift of A. Krensky (Dana-Farber Cancer Institute, Boston) and was added at 2 units/ml.
TT-Specific T-Cell Lines. TT-specific T-cell lines were generated as described by Kurnick et al. (11) . The cell lines were resuspended every 3-4 days in fresh medium containing 25% IL-2-containing supernatants and were stimulated every 7-10 days with autologous irradiated (5000 rads) PBMC and TT.
Generation and Testing of IL-1-Containing Supernatants.
IL-i-containing supernatants were generated by incubating adherent PBMC (2-5 x 106 per ml) with Con A (20 ,ug/ml) for 18 hr, collecting the supernatants, and adding a-methyl-D-mannoside (25 mg/ml) as described in ref. 10 . Such supernatants contain IL-1 activity, as assessed by a thymocyte costimulator assay (3), and can substitute for IL-i in reconstituting the human T-cell proliferative response to TTpulsed UV-irradiated Mo (3). IL-1 activity in the supernatants was assayed as in ref. 3 . Briefly, Mo in Petri dishes were incubated with TT (50 ,ug/ml) for 18 hr, washed, irradiated with UV light (1.2 joules/m2 per sec, 230-350 nm) for 60 sec, and then added at a ratio of 1:10 to nylon wool-purified autologous T cells in the presence or absence of supernatants to be tested for IL-1 activity. PHA was added at a concentration of 1 ,ug/mi, TT and diphtheria toxoid (DT, Massachusetts Biological Laboratories, Jamaica Plain, MA) were added at a concentration of 20 ,ug/ml, and monilia antigen (Hollister Stier, Spokane, WA) was added at a dilution of 1:500. Values represent mean ± SEM of triplicate cultures. Mitogen-stimulated cultures were harvested at 3 days and the remainder at 6 days. The background for unstimulated 6-day cultures is shown and was not significantly different from the background for 3-day cultures, which is not shown. Normal subjects ranged in age from 7 to 25 years. TT pre and post indicate before and after immunization, respectively, with TT.
gen assay (12, 13) , in which one rabbit pyrogen dose is the amount of IL-1/LP that when injected intravenously in a rabbit causes an elevation of 0.6-0.90C in body temperature within 1 hr.
Thymocyte Costimulator Assay. This was performed as described in ref. 13 .
RESULTS
Response to Mitogens and Antigens. PBMC from the patient had a diminished proliferative response (<3 SD below the mean of normal controls) to PHA, Con A, and pokeweed mitogen (PWM) and an absent response to TT, diphtheria toxoid, and monilia antigens (Table 1) . Subsequently, the patient and his mother, who was not immune to TT, were given a series of three immunizations with TT antigen (5 limit flocculation units each) over a 2-month period. Following this, PBMC from the patient remained unresponsive to TT, whereas PBMC from his healthy mother proliferated vigorously to TT (Table 1) . After immunization, the delayed hypersensitivity skin test with TT remained negative in the patient but converted to positive in the mother. express Ia antigen compared to 82% ± 14% in five normal controls.
To examine the antigen-presenting function of the patient's Mo and because no HLA identical siblings were available, we examined the capacity of his Mo to support the proliferation of a TT-specific T-cell line derived from his HLA haploidentical mother. The results of this experiment are shown in Fig. 1 . Mo from the patient and from the mother supported T-cell proliferation of the maternal T-cell line in the presence of TT. Mo from an HLA-DR unrelated donor failed to support the proliferation of the maternal T-cell line in the presence of TT.
We next examined the capacity of the patient's Mo to generate IL-1 and found it to be normal. Table 2 shows that normal immune T cells proliferated in response to TT-pulsed autologous Mo but not in response to autologous TT-pulsed UV-irradiated Mo. This response was reconstituted by the addition of supernatants from Con A-stimulated Mo derived from both the patient and a normal donor. This effect was not due to residual Con A in the Mo supernatants because addition of these supernatants alone did not cause proliferation of T cells and Mo.
IL-2 Production and Response. Fig. 2A shows that the patient's PBMC were severely deficient in their capacity to generate IL-2 for the normal IL-2-dependent T-cell line. Although the patient's PBMC failed to generate IL-2, Con Ainduced blasts from the patient were able to respond to IL-2, as shown in Fig. 2B , but not to supernatants of his own PHAstimulated PBMC. Thus, it appears that the T cells of the patient respond normally to IL-2, even though his PBMC were unable to generate it. Mixing experiments failed to de- (Table 3 ). In contrast to the effect of IL-2 on the PHA response, addition of PHA-free IL-2 to cultures for the' patient's PBMC stimulated with TT did not result in cell proliferation (data not shown). Addition of purified IL-1 to the patient's PBMC did not correct their defective proliferative responses (data not shown).
Response to Phorbol 12-Myristate 13-Acetate (PM'A). We next considered the possibility that the failure of the patient's T cells to make IL-2 was due to their failure to respond to IL-1. In an effort to bypass the IL-1 requirement for lectin-induced IL-2 production, we examined the capacity of the patient's PBMC to produce IL-2 activity when stimulated with PHA in the presence of the phorbol ester PMA. Table 4 shows that when the patient's PBMC were stimulated with both PHA and PMA they released substantial amounts of IL-2 activity into their supernatants. Stimulation of the patient's PBMC with either PHA or PMA alone did not result in the release of significant IL-2 activity as assessed by blast proliferation (Table 4 ). The blast proliferation induced by supernatants of PBMC stimulated with PMA and PHA was not due to the action of these agents together on the blasts used for the assay (Table 4) . PMA induced a negligible increment or no increment in the production of IL-2 by PHA-stimulated normal T cells (data not shown).
We next examined the capacity of T-cell blasts from the patient and from a normal subject to absorb IL-1 activity. Con A-induced T-cell blasts from normal individuals and from the patient were propagated in culture for 4 weeks by the addition of IL-2. No differences could be discerned in their response to IL-2. Fig. 3 depicts the activity of purified IL-1 in a mouse thymocyte stimulator assay folloWing its absorption with Con A-induced T-cell blasts from the patient and a normal control. IL-1 activity was absorbed by normal T-cell blasts but not by the patient's T-cell blasts. T-cell blasts from both patient and a normal control completely absorbed IL-2 activity from IL-2-containing supernatants (data not shown).
DISCUSSION
The present study describes a defective T-cell response to the monokine IL-1 in a child with immunodeficiency. This was supported by the following three findings. (i) Despite the production of normal IL-i activity by the patient's Mo, the IL-i-dependent induction of IL-2 by PHA was severely deficient (Fig. 2). (ii) The failure to produce IL-2 following stimulation with PHA was corrected, by the addition of an agent that mimics the effect of IL-1 (Table 4 ). (iii) T-cell blasts from the patient, in contrast to normal T-cell blasts, failed to absorb IL-1 activity from a preparation of purified IL-1 (Fig.  3) .
Mitogen-induced IL-2 production has been shown to require IL-1 (14) (15) (16) . Failure to produce IL-2 in the face of normal IL-1 production in our patient suggested that his T cells either were unable to respond to IL-1 or were intrinsically unable to produce IL-2. The latter possibility was ruled out by demonstrating normal IL-2 production in the presence of PHA and PMA, which can act as an IL-1 analogue in the activation of Mo/macrophage-depleted T lymphocytes (7, 17, 18) . Although PMA also enhances IL-1 secretion (19, 20) , it is unlikely that its effect of the patient's cells was mediated by this mechanism because the patient's Mo produced IL-1 normally. Thus, it appeared that our patient's T cells failed to respond normally to IL-1. This could have resulted from defective binding of IL-1 to T cells, which was supported by the observation that the patient's T cells exhibited a decreased capacity to absorb IL-1 when compared to normal T cells (Fig. 3) . Absorption of IL-1 by T-cell blasts has been demonstrated in the mouse by Gillis and Mizel (21) . In agreement with their findings, we had to use large numbers of normal T-cell blasts to absorb IL-1. This suggests that the affinity of the T cell for IL-1 is low. The findings in the present study have important implica- Our patient had absence of delayed hypersensitivity responses to antigens in vivo and his PBMC failed to proliferate to antigens in vitro, including TT antigen with which he was repeatedly immunized. The failure of our patient's PBMC to proliferate to TT could have resulted from his defective response to IL-1. Indeed, we and others have demonstrated a requirement for IL-1 in the proliferative response of human T cells to antigen (2, 3, 22) . In particular, antibody to human IL-1 markedly inhibits the response of human PBMC to TT antigen (3) . In contrast to the situation with PHA, IL-2 did not correct the failure of the patient's PBMC to respond to TT antigen. This may be related to the fact that initial proliferation occurred with PHA that allowed a subsequent response to exogenous IL-2, while no proliferation at all occurred with TT antigen. In addition, it is possible that in the presence of a defective response to IL-1 the expansion of TT-immune T cells in vivo did not occur. Because PMA was mitogenic for resting human lymphocytes, including our patient's, we could not use PMA to substitute for the IL-1 signal in antigen-driven responses.
Inability to produce normal amounts of IL-2 in the face of normal or increased capacity to generate IL-1 has been described in nude mice. Peritoneal macrophages from these mice produce supranormal amounts of lymphocyte-activating factor, subsequently termed IL-1 (23) . Their thymocytes fail to proliferate and to generate IL-2 after mitogen stimulation. Addition of both mitogen and a source of exogenous IL-2 induces normal proliferative responses (24) . The findings in the nude mouse are analogous to those made in our patient and suggest that he may have suffered from a T-cell maturation defect. In this regard, a number of T-cell leukemias are unable to produce IL-2 in the presence of PHA and normal Mo as a source of IL-1 but do so in the presence of added phorbol ester (25) . Inasmuch as T-cell leukemias represent malignant transformation of T cells frozen at a particular stage in their differentiation, these observations also suggest that our patient suffered from a T-cell maturation defect. The history of three siblings having died in infancy with recurrent infections raises the possibility that the defect in our patient was inherited. Because of geographic constraints only one of the patient's five healthy siblings was studied and was found to be normal.
